Ki-67、MCM2、p16在宫颈鳞状上皮内病变中表达及意义

doi:10.20223/j.cnki.1000-8535.2025.01.012

摘要/Abstract

摘要： 目的探讨Ki-67、微小染色体维持蛋白2（MCM2）、p16在宫颈鳞状上皮内病变中的表达及其临床意义。方法采用免疫组化检测Ki-67、MCM2、p16在宫颈炎症组14例、低级别鳞状上皮内病变（LSIL）组47例、高级别鳞状上皮内病变（HSIL）组49例中的表达情况,以病理结果作为金标准,对结果进行统计分析。结果 HSIL组中Ki-67、MCM2、p16阳性率均高于炎症组和LSIL组（均P<0.017）。HSIL组中Ki-67、MCM2过表达率均显著高于炎症组和LSIL组（均P<0.017）。随着宫颈病变级别增加,Ki-67及MCM2阳性范围从基底层至表层逐渐扩大。MCM2及Ki-67在LSIL组中表达模式多为基底层的非过表达模式,HSIL组多为中层及以上的过表达模式。Spearman相关性分析显示,MCM2和Ki-67在宫颈鳞状上皮内病变中的表达强度之间呈正相关（r=0.801,P<0.05）;p16与MCM2在宫颈鳞状上皮内病变中的表达呈正相关（r=0.559,P<0.05）;p16与Ki-67在宫颈鳞状上皮内病变中的表达呈正相关（r=0.478,P<0.05）。结论 p16阳性提示宫颈高级别鳞状上皮内病变。MCM2与Ki-67在宫颈鳞状上皮内病变中的表达具有较高一致性,MCM2可作为宫颈鳞状上皮内病变新的增殖标志物。

关键词: 宫颈鳞状上皮内病变, Ki-67, 微小染色体维持蛋白2, p16

Abstract: Objective To investigate the expression and significance of Ki-67,MCM2 and p16 in cervical intraepithelial lesions．Methods The expressions of Ki-67,MCM2 and p16 in cervicitis group（14 cases）,low-grade squamous intraepithelial lesion（LSIL） group（47 cases）and high-grade squamous intraepithelial lesion（HSIL） group（49 cases）were detected by immunohistochemistry．The pathological results were used as the gold standard for statistical analysis．Results The positive rates of Ki-67,MCM2 and p16 in HSIL group were significantly higher than those in cervicitis group and LSIL group（P<0.017）．The over-expression rates of Ki-67,MCM2 in HSIL group were significantly higher than those in cervicitis group and LSIL group（P<0.017）．With the increase of cervical lesion grade,the positive range of Ki-67 and MCM2 gradually expanded from basal layer to surface layer．The expression patterns of MCM2 and Ki-67 in LSIL group were mostly non-overexpressed in the basal layers,while those in HSIL group were mostly overexpressed in the middle layer and above．Spearman correlation analysis showed that the expression intensity of MCM2 and Ki-67 in cervical squamous intraepithelial lesions was positively correlated（r=0.801,P<0.05）．There was a positive correlation between the expression of p16 and MCM2 in cervical squamous intraepithelial lesions（r=0.559,P<0.05）．There was a positive correlation between the expression of p16 and Ki-67 in cervical squamous intraepithelial lesions（r=0.478,P<0.05）．Conclusions Positive p16 indicates high-grade squamous intraepithelial lesion．The expression of MCM2 and Ki-67 in cervical intraepithelial lesions is highly consistent．MCM2 can be used as a new proliferative marker for cervical intraepithelial lesions．

Key words: cervical intraepithelial lesions, Ki-67, MCM2, p16

温俊秀, 张可心, 王琦, 宋慧茹, 倪璐, 宋旭东. Ki-67、MCM2、p16在宫颈鳞状上皮内病变中表达及意义[J]. 广州医药, 2025, 56(1): 82-88.

WEN Junxiu, ZHANG Kexin, WANG Qi, SONG Huiru, NI Lu, SONG Xudong. Analysis of the expression and significance of Ki-67、MCM2 and p16 in cervical intraepithelial lesions[J]. Guangzhou Medical Journal, 2025, 56(1): 82-88.

参考文献

[1] SINGH D,VIGNAT J,LORENZONI V,et al.Global estimates of incidence and mortality of cervical cancer in 2020:A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative[J].Lancet Glob Health,2023,11(2):e197-e206.
[2] 邱丽华,陈飞,赵卫东,等.2024子宫颈癌筛查和早期精准诊断现状白皮书[J].中国实用妇科与产科杂志,2024,40(1):85-95.
[3] SERRA S,CHETTY R.p16:Gene of the Month[J].J Clin Pathol,2018,71(10):853-858.
[4] ISSAC M S M,YOUSEF E,TAHIR M R,et al.MCM2,MCM4,and MCM6 in breast cancer:Clinical utility in diagnosis and prognosis[J].Neoplasia,2019,21(10):1015-1035.
[5] SAMAD A,HAQUE F,NAIN Z,et al.Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer[J].Heliyon,2020,6(10):e05087.
[6] AUNG T N,ACS B,WARRELL J,et al.A new tool for technical standardization of the Ki67 immunohistochemical assay[J].Mod Pathol,2021,34(7):1261-1270.
[7] SHI Q,XU L,YANG R,et al.Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions[J].Oncol Lett,2019,18(2):1351-1355.
[8] 武振宇. HPVE6/E7 mRNA和HPV-DNA检测在宫颈癌筛查中的价值[J].川北医学院学报,2022,37(10):1313-1316.
[9] ESTÊVÃO D,COSTA N R,GIL DA COSTA R M,et al.Hallmarks of HPV carcinogenesis:The role of E6,E7 and E5 oncoproteins in cellular malignancy[J].Biochim Biophys Acta Gene Regul Mech,2019,1862(2):153-162.
[10] EBISCH R M F,RIJSTENBERG L L,SOLTANI G G,et al.Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population[J].Acta Obstet Gynecol Scand,2022,101(11):1328-1336.
[11] 游伟强,王莉平,吴小延,等.p16和HPV DNA检测在ASC-US分流中的价值研究[J].广州医药,2022,53(4):30-35,41.
[12] DA MATA S,FERREIRA J,NICOLÁS I,et al.P16 and HPV genotype significance in HPV-associated cervical cancer-a large cohort of two tertiary referral centers[J].Int J Mol Sci,2021,22(5).
[13] 蒋莉萍,吴凤珍,肖艳,等.p16、微型染色体维持蛋白2、Ki-67在宫颈鳞状上皮内病变的表达与意义[J].现代医学与健康研究电子杂志,2021,5(17):35-38.
[14] World Health Organization.Female genital tumours. IARC.WHO classification of tumours.5th Edition[EB/OL].[2021-01-25].https://tumourclassification.iarc.who.int/9789283245049.
[15] GUO F,KONG W N,FENG Y C,et al.Comprehensive analysis of the expression and prognosis for MCMs in human gastric cancer[J].Technol Cancer Res Treat,2020(19):1533033820970688.
[16] HSU E C,SHEN M,ASLAN M,et al.MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer[J].Sci Rep,2021,11(1):13305.
[17] VIVATVAKIN S,RATCHATASWAN T,LEESUTIPORNCHAI T,et al.MCM-2,Ki-67,and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma[J].Sci Rep,2021,11(1):14607.
[18] ÜNAL Ç,ÖZMEN T,İLGüN A S,et al.MCM-2 levels as a potential biomarker for predicting high-risk breast cancer patients according to TAILORx classification[J].Breast Cancer(Dove Med Press),2023(15):659-669.
[19] MENON S S,GURUVAYOORAPPAN C,SAKTHIVEL K M,et al.Ki-67 protein as a tumour proliferation marker[J].Clin Chim Acta,2019,491:39-45.
[20] ACHARYA S,ARNOLD D,PRABHU P,et al.MCM-2 an alternative to Ki-67 for assessing cell proliferation in odontogenic pathologies[J].J Oral Med Pathol,2019,31(1):52-58.
[21] SWAIN S,NISHAT R,RAMACHANDRAN S,et al.Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma[J].J Cancer Res Ther,2022,18(4):997-1002.
[22] 张仁超,李镔薇,赵东晖等.联合检测P16及Ki67在宫颈鳞状上皮内病变中的表达及临床意义[J].现代诊断与治疗,2023,34(6):879-881.
[23] 王登山,曹磊,钱金林等.HPVL1壳蛋白联合MCM2检测对HPV DNA阳性患者宫颈病变的诊断及预后意义[J].现代肿瘤医学,2020,28(2):287-292.
[24] DERBIE A,MEKONNEN D,WOLDEAMANUEL Y,et al.HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia(CIN2+):A systematic review[J].Infect Agent Cancer,2020(15):9.
[25] GUTIÉRREZ-HOYA A,SOTO-CRUZ I.Role of the JAK/STAT Pathway in Cervical Cancer:Its Relationship with HPV E6/E7 Oncoproteins[J].Cells,2020,9(10).
[26] ZHENG J.Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection[J].Int J Clin Exp Pathol,2015,8(1):875-880.